Cargando...
Immunotherapy in colorectal cancer: for the select few or all?
Over the past few years, the role of immunotherapy in colorectal cancer (CRC) has expanded, specifically in subsets of CRC with microsatellite instability (MSI) for which newer agents, such as programmed death-1 (PD-1) inhibitors, are efficacious. While other immunotherapeutic agents are more immatu...
Guardado en:
| Publicado en: | J Gastrointest Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848030/ https://ncbi.nlm.nih.gov/pubmed/29564183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.06.10 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|